Seeking Alpha

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial ...

Bioxtreme Announces Strategic Investment Led by Serra Holding and Introduces Plaxtreme to Accelerate Neurorehabilitation Innovation

Bioxtreme, an innovator in neurorehabilitation technologies leveraging its proprietary error augmentation approach to accelerate motor recovery, today announced a new strategic investment led by Serra ...
Communications of the ACM

The New Era of Sensory Augmentation

Nowhere is this convergence more evident than in the emerging field of sensory augmentation, where artificial intelligence ...
TCTMD

reBEAT: Biventricular Epicardial Augmentation Technology for HF Patients: Introducing a Novel MCS Technology, First-in-Human Translational Insights, Strategy for Pivotal Trial ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Business Insider

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition | Markets Insider

HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial ...